Drug Profile
P 56
Alternative Names: P-56Latest Information Update: 18 Nov 2003
Price :
$50
*
At a glance
- Originator Nonindustrial source
- Developer Nonindustrial source; Phytopharm
- Class
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Hepatitis B; Hepatitis C
Most Recent Events
- 18 Nov 2003 Discontinued - Preclinical for Hepatitis B in India (unspecified route)
- 18 Nov 2003 Discontinued - Preclinical for Hepatitis C in United Kingdom (unspecified route)
- 06 Jul 2000 Preclinical development for Hepatitis C in United Kingdom (Unknown route)